HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

1-(4-octylphenethyl)piperidin-4-ol

structure in first source

Also Known As:

RB-005

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Piperidines: 17
    - 1-(4-octylphenethyl)piperidin-4-ol: 1

Experts

1.	Al Washih, Mohammed: 1 article (01/2016)
2.	Futerman, Anthony H: 1 article (01/2016)
3.	Kennedy, Simon: 1 article (01/2016)
4.	MacRitchie, Neil: 1 article (01/2016)
5.	Pyne, Nigel J: 1 article (01/2016)
6.	Pyne, Susan: 1 article (01/2016)
7.	Volpert, Giora: 1 article (01/2016)
8.	Watson, David G: 1 article (01/2016)

Related Diseases

1.	Right Ventricular Hypertrophy 01/01/2016 - "In contrast, RB-005 lacked effects on right ventricular hypertrophy, suggesting that sphingosine kinase 1 inhibition might be nullified by concurrent inhibition of ceramide synthase. "
2.	Pulmonary Arterial Hypertension 01/01/2016 - "Therefore, we assessed the effect of the sphingosine kinase 1 selective inhibitor, PF-543 and a sphingosine kinase 1/ceramide synthase inhibitor, RB-005 on pulmonary and cardiac remodelling in a mouse hypoxic model of pulmonary arterial hypertension. "

Related Drugs and Biologics

1.	PF-543
2.	dihydroceramide desaturase
3.	sphingosine kinase